Neo Ivy Capital Management’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,214
Closed -$559K 346
2025
Q1
$559K Sell
4,214
-28,732
-87% -$3.66M 0.18% 172
2024
Q4
$3.73M Buy
+32,946
New +$3.81M 0.75% 28
2023
Q4
Sell
-7,628
Closed -$739K 275
2023
Q3
$739K Buy
+7,628
New +$801K 0.32% 109
2022
Q4
Sell
-1,042
Closed -$101K 314
2022
Q3
$101K Buy
+1,042
New +$111K 0.27% 144
2022
Q2
Sell
-1,152
Closed -$136K 385
2022
Q1
$136K Buy
+1,152
New +$143K 0.12% 263
2021
Q3
Sell
-460
Closed -$53K 440
2021
Q2
$53K Buy
460
+143
+45% +$16.7K 0.05% 316
2021
Q1
$38K Buy
+317
New +$37.6K 0.04% 354
2020
Q2
Sell
-611
Closed -$48K 441
2020
Q1
$48K Buy
+611
New +$51K 0.08% 311

Other funds holding ABT

Neo Ivy Capital Management's ABT Position: Q2 2025 in Review

Neo Ivy Capital Management sold out of Abbott (ABT) in Q2 2025, closing a stake of 4,214 shares — an estimated $559K sold.

Neo Ivy Capital Management first reported a position in ABT in Q1 2020 and held it in 8 quarters. The position peaked at $3.73M in Q4 2024. 3,184 funds tracked by Wall St. Rank hold ABT as of Q2 2025.

  • Neo Ivy Capital Management reported no remaining Abbott position as of Q2 2025 after selling out during the quarter.
  • Neo Ivy Capital Management sold 4,214 Abbott shares in Q2 2025, an estimated $559K.
  • Neo Ivy Capital Management first reported a position in Abbott in Q1 2020 and held it in 8 quarters.
  • Neo Ivy Capital Management's Abbott position peaked at $3.73M in Q4 2024.
  • 3,184 funds tracked by Wall St. Rank held Abbott as of Q2 2025.

Based on Neo Ivy Capital Management's 13F filing for Q2 2025, filed 12 Aug 2025.